Bausch Health Companies Inc
Research Bausch Health Companies Inc (BHC) on Bullrun: market cap USD 2.52B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerBHC
- ExchangeNYSE
- CountryCanada
- SectorHealthcare
- IndustryDrug Manufacturers-Specialty & Generic
- CurrencyUSD
- Market capUSD 2.52B
- Financial periodQ2 2026
- RevenueUSD 2.85B
- Net incomeUSD 258.00M
- Free cash flowUSD 593.00M
- Gross margin72.9%
Valuation Snapshot
latest market cap is USD 2.52B.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 10.27B | USD 157.00M | USD 1.00B | 70.7% | 0.42 | USD 1.31B | USD 20.82B | -USD 554.00M |
| FY2024 | USD 9.63B | -USD 46.00M | USD 1.26B | 71.1% | -0.13 | USD 1.18B | USD 21.62B | -USD 1.28B |
| FY2023 | USD 8.76B | -USD 592.00M | USD 817.00M | 70.8% | -1.62 | USD 947.00M | USD 22.39B | -USD 1.02B |
| FY2022 | USD 8.12B | -USD 225.00M | -USD 946.00M | n/a | -0.62 | USD 564.00M | USD 20.77B | -USD 692.00M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 2.52B | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 2.58B | 17.0 | n/a | n/a |
| 2024 | 2024-12-31 | USD 2.96B | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 2.93B | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 2.27B | 9.0 | n/a | n/a |
| 2021 | 2021-12-31 | USD 9.92B | n/a | n/a | n/a |
About Bausch Health Companies Inc
Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company. It operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The company develops, manufactures, and markets products primarily in the therapeutic areas of gastroenterology, hepatology, neurology and dermatology, generic and branded generic pharmaceuticals, dentistry products, over-the-counter products, aesthetic medical devices, and eye health.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Bausch Health Companies Inc's market cap?
Bausch Health Companies Inc's market capitalization is USD 2.52B.
What does Bausch Health Companies Inc do?
Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company. It operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The company develops, manufactures, and markets products primarily in the therapeutic areas of gastroenterology, hepatology, neurology and dermatology, generic and branded generic pharmaceuticals, dentistry products, over-the-counter products, aesthetic medical devices, and eye health.